Short-chain fatty acids,metabolites produced by the fermentation of dietary fiber by gut microbiota,have garnered significant attention due to their correlation with neurodegenerative diseases,particularly Parkinson’...Short-chain fatty acids,metabolites produced by the fermentation of dietary fiber by gut microbiota,have garnered significant attention due to their correlation with neurodegenerative diseases,particularly Parkinson’s disease.In this review,we summarize the changes in short-chain fatty acid levels and the abundance of short-chain fatty acid-producing bacteria in various samples from patients with Parkinson’s disease,highlighting the critical role of gut homeostasis imbalance in the pathogenesis and progression of the disease.Focusing on the nervous system,we discuss the molecular mechanisms by which short-chain fatty acids influence the homeostasis of both the enteric nervous system and the central nervous system.We identify key processes,including the activation of G protein-coupled receptors and the inhibition of histone deacetylases by short-chain fatty acids.Importantly,structural or functional disruptions in the enteric nervous system mediated by these fatty acids may lead to abnormalα-synuclein expression and gastrointestinal dysmotility,which could serve as an initiating event in Parkinson’s disease.Furthermore,we propose that short-chain fatty acids help establish communication between the enteric nervous system and the central nervous system via the vagal nerve,immune circulation,and endocrine signaling.This communication may shed light on their potential role in the transmission ofα-synuclein from the gut to the brain.Finally,we elucidate novel treatment strategies for Parkinson’s disease that target short-chain fatty acids and examine the challenges associated with translating short-chain fatty acid-based therapies into clinical practice.In conclusion,this review emphasizes the pivotal role of short-chain fatty acids in regulating gut-brain axis integrity and their significance in the pathogenesis of Parkinson’s disease from the perspective of the nervous system.Moreover,it highlights the potential value of short-chain fatty acids in early intervention for Parkinson’s disease.Future research into the molecular mechanisms of short-chain fatty acids and their synergistic interactions with other gut metabolites is likely to advance the clinical translation of innovative short-chain fatty acid-based therapies for Parkinson’s disease.展开更多
The global prevalence of metabolic-associated fatty liver disease(MAFLD)is on the rise,seriously threatening human health.Currently,no specific approved drugs are available for its treatment.This paper reviews the pat...The global prevalence of metabolic-associated fatty liver disease(MAFLD)is on the rise,seriously threatening human health.Currently,no specific approved drugs are available for its treatment.This paper reviews the pathogenesis of MAFLD,covering aspects like lipid accumulation and insulin resistance,oxidative stress,endoplasmic reticulum stress(ERS),lipotoxicity-induced hepatocyte damage,and fibrosis.It also elaborates on multiple treatment approaches for MAFLD,including metabolic regulation,improvement of the gut-liver axis interaction,modulation of immune and inflammatory pathways,enhancement of the adipose tissue-liver interaction,alleviation of fibrosis,prevention of hepatocyte injury,and traditional Chinese medicine(TCM)external therapies.Additionally,natural product research advancements,individual Chinese medicine components,and mixed herbal formulas for MAFLD treatment is provided.Many natural products and traditional Chinese medicines exhibit favorable effects in regulating lipid metabolism,anti-inflammation,and anti-oxidation,offering new directions and potential drug options for MAFLD treatment.This is expected to provide a reference for future clinical treatment and drug development.展开更多
Dysregulated inflammation and multi-organ failure are hallmarks of sepsis,a potentially fatal illness for which there are currently no effective treatments.Fatty acid-binding protein(A-FABP)has been identified in rece...Dysregulated inflammation and multi-organ failure are hallmarks of sepsis,a potentially fatal illness for which there are currently no effective treatments.Fatty acid-binding protein(A-FABP)has been identified in recent research as a crucial mediator of the inflammatory pathways underlying sepsis.In this study,we used a murine model of lipopolysaccharide(LPS)-induced endotoxemia to assess the therapeutic potential of 6H2,a monoclonal antibody that targets A-FABP.In comparison to untreated septic mice,6H2 treatment significantly increased survival rates,decreased histopathological damage in the liver,lungs,kidneys,and heart,and reduced systemic inflammation.According to biochemical analyses,6H2 treatment decreased circulating levels of A-FABP,and this was associated with a reduction in inflammatory markers.These results indicate that A-FABP inhibition is a potentially effective treatment approach for sepsis,with 6H2 demonstrating strong therapeutic efficacy.展开更多
Alternate wetting and drying irrigation(AWD)significantly influences the cooking and eating quality of rice(Oryza sativa L.).However,the mechanisms by which AWD affects rice cooking and eating quality remain unclear.L...Alternate wetting and drying irrigation(AWD)significantly influences the cooking and eating quality of rice(Oryza sativa L.).However,the mechanisms by which AWD affects rice cooking and eating quality remain unclear.Lipid and free fatty acid contents in grains correlate positively with cooking and eating quality of rice.This study examined Yangdao 6(YD6,a conventional taste indica inbred)and Nanjing 9108(NJ9108,a superior taste japonica inbred)cultivated under conventional irrigation(CI),alternate wetting and moderate drying irrigation(AWMD),and alternate wetting and severe drying irrigation(AWSD)from 10 days after transplanting to maturity.The research investigated the relationship between lipid and free fatty acid biosynthesis in grains and the cooking and eating quality of rice.Compared to CI treatment,AWMD significantly enhanced the contents of lipid,total free fatty acids(TFFAs),free unsaturated fatty acids(FUFAs),linoleic acid,and oleic acid in milled rice by increasing activities of enzymes associated with lipid synthesis,while AWSD produced opposite effects.Correlation analysis revealed that elevated levels of lipid,TFFAs,FUFAs,linoleic acid,and oleic acid contribute to improved rice cooking and eating quality.The findings demonstrate that AWMD enhances cooking and eating quality of milled rice through optimization of lipid and fatty acid synthesis in rice grains.展开更多
Epidemiological evidence suggests that there is a direct relationship between the degree of obesity and acute pancreatitis severity.Intake of different fatty acids leads to different types of hyperlipidemias.Adipose d...Epidemiological evidence suggests that there is a direct relationship between the degree of obesity and acute pancreatitis severity.Intake of different fatty acids leads to different types of hyperlipidemias.Adipose degradation by pancreatic lipase generates different free fatty acids,which can exacerbate pancreatitis.Saturated fatty acids(SFAs)play an inflammatory role in human metabolic syndrome and obesity,whereas unsaturated fatty acids(UFAs)are“good fats”that are thought to enhance overall health status.However,it appears that serum UFAs correlate with severe acute pancreatitis.Additionally,the“obesity paradox”suggests that UFAs potentially minimize direct harm to the organ.This review provides an in-depth overview of the role of SFAs and UFAs in acute pancreatitis of hyperlipidemia and discusses potential prevention targets for severe acute pancreatitis.展开更多
Non-alcoholic fatty liver disease(NAFLD),also referred to as metabolic-associated fatty liver disease,is among the most prevalent chronic liver conditions.In some cases,NAFLD may lead to liver inflammation and non-alc...Non-alcoholic fatty liver disease(NAFLD),also referred to as metabolic-associated fatty liver disease,is among the most prevalent chronic liver conditions.In some cases,NAFLD may lead to liver inflammation and non-alcoholic steatohepatitis,which can eventually progress to liver cirrhosis and hepatocellular carcinoma.The pathophysiology of NAFLD is complex,involving both genetic and environmental factors.NAFLD is a multisystem disease linked to a higher likelihood of developing metabolic disorders such as type 2 diabetes,obesity,and cardiovascular and chronic kidney diseases.The gut-liver axis represents a key connection between the gut microbiota and the liver,and its disruption has been linked to NAFLD.Growing evidence underscores the significant role of gut microbiota in the onset and progression of NAFLD,with alterations in the gut microbiome and impaired gut barrier function.Studies have identified key microbiota signatures and metabolites linked to NAFLD,implicating oxidative stress,endotoxemia,and inflammatory pathways that further strengthen the connection between gut microbiota and NAFLD.Modulation of gut microbiota through diet and microbiota-centered therapies,such as next-generation probiotics and fecal microbiota transplantation,holds promise for treating NAFLD.In this review,we explore the key link between gut microbiota and the development and progression of NAFLD,as well as its potential applications in the diagnosis and treatment of the disease.展开更多
Metabolic-associated fatty liver disease(MAFLD),formerly known as nonalcoho-lic fatty liver disease,is an increasing global health challenge with substantial implications for metabolic and cardiovascular health(CVH).A...Metabolic-associated fatty liver disease(MAFLD),formerly known as nonalcoho-lic fatty liver disease,is an increasing global health challenge with substantial implications for metabolic and cardiovascular health(CVH).A recent study by Fu et al investigated the relationship between CVH metrics,specifically Life’s Simple 7 and Life’s Essential 8,and the prevalence of MAFLD.While this study offered important insights into the relationship between CVH and MAFLD,several me-thodological limitations,unaddressed confounding factors,and potential biases that could impact the interpretation of their findings should be considered.The study’s cross-sectional nature restricted the ability to draw causal conclusions,and it did not fully account for potential confounding factors such as dietary habits,genetic predispositions,and medication use.Furthermore,relying on tran-sient elastography to diagnose MAFLD introduces certain diagnostic limitations.Longitudinal study designs,advanced statistical modeling techniques,and diverse population groups should be utilized to strengthen future research.Exploring the mechanistic pathways that link CVH metrics to MAFLD through multi-omics approaches and interventional studies will be essential in formulating targeted prevention and treatment strategies.Structural equation modeling and machine learning techniques could provide a more refined analysis of these interrelated factors.Additionally,future research should employ longitudinal study designs and explore genetic and epigenetic influences to enhance our un-derstanding of CVH and MAFLD interactions.展开更多
Non-alcoholic fatty liver disease(NAFLD)is the fastest-growing global contributor to the disease burden associated with the consequences of chronic liver disease,including cirrhosis and liver cancer.It is projected th...Non-alcoholic fatty liver disease(NAFLD)is the fastest-growing global contributor to the disease burden associated with the consequences of chronic liver disease,including cirrhosis and liver cancer.It is projected that more than fifty percent of the adult population,including women,smokers,and individuals without metabolic syndrome,will have NAFLD by 2040.Various mechanisms linking the gut microbiome to NAFLD and the consequent fibrosis have been discerned,which suggest the dysbiosis-induced impairment of gut endothelial barrier function,leading to hepatic inflammation through the translocation of bacterial components.NAFLD is progressively associated with environmental variables,especially exposure to heavy metals that impair liver metabolism,produce oxidative stress,and exacerbate inflammation,hence accelerating its progression.These toxicants also modify the composition of gut microbiota,hence intensifying liver damage.Comprehending the processes by which heavy metals contribute to NAFLD is essential for formulating tailored therapies.This review examines strategies to alleviate liver toxicity caused by heavy metals,including chelation therapy,dietary modifications(antioxidants and hepatoprotective nutrients),gut microbiome modulation via probiotics and postbiotics like short-chain fatty acids to restore intestinal barrier function and use of essential minerals like selenium,with potent antioxidant characteristics.Employing these measures may offer an integrated approach for addressing NAFLD in individuals subjected to heavy metal poisoning.展开更多
Non-alcoholic fatty liver disease(NAFLD)has become the most prevalent chronic liver disease globally,with its incidence rising annually.It can progress to cirrhosis and even hepatocellular carcinoma,posing a serious t...Non-alcoholic fatty liver disease(NAFLD)has become the most prevalent chronic liver disease globally,with its incidence rising annually.It can progress to cirrhosis and even hepatocellular carcinoma,posing a serious threat to human health.Stress can participate in the pathological process of NAFLD by activating inflammatory responses and regulating levels of inflammatory mediators,with hepatocyte injury being a core component of NAFLD progression.This paper focuses on three key stress-related inflammatory mediators:tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),and C-reactive protein(CRP),elucidating their core mechanisms in the pathway related to stress signal,followed by inflammatory activation and hepatocyte injury respectively,and reviewing current research.Research indicates that certain inflammatory mediators can damage hepatocytes by directly inducing apoptosis or indirectly regulating metabolic disorders and fibrosis progression.However,questions regarding causal relationships,target specificity for intervention,and quantification of psychological stress remain unresolved.This paper aims to provide theoretical support for NAFLD intervention strategies targeting inflammatory mediators,clarifying future research directions to advance clinical translation.展开更多
The potential of induced pluripotent stem cells(iPSCs)for modeling and treating metabolic associated fatty liver disease(MAFLD)and metabolic associated steatohepatitis(MASH)is emerging.MAFLD is a growing global health...The potential of induced pluripotent stem cells(iPSCs)for modeling and treating metabolic associated fatty liver disease(MAFLD)and metabolic associated steatohepatitis(MASH)is emerging.MAFLD is a growing global health concern,currently with limited treatment options.While primary mesenchymal stem cells hold promise,iPSCs offer a versatile alternative due to their ability to differentiate into various cell types,including iPSC-derived mesenchymal stem cells.However,challenges remain,including optimizing differentiation protocols,ensuring cell safety,and addressing potential tumorigenicity risks.In addition,iPSCs offer the possibility to generate complex cellular models,including three-dimensional organoid models,which are closer representations of the human disease than animal models.Those models would also be valuable for drug discovery and personalized medicine approaches.Overall,iPSCs and their derivatives offer new perspectives for advancing MAFLD/MASH research and developing novel therapeutic strategies.Further research is needed to overcome current limitations and translate this potential into effective clinical applications.展开更多
With the shift in the definition of disease from non-alcoholic fatty liver disease(NAFLD)to metabolism-associated fatty liver disease(MAFLD),as well as the rapid evolution of pathological classification and therapeuti...With the shift in the definition of disease from non-alcoholic fatty liver disease(NAFLD)to metabolism-associated fatty liver disease(MAFLD),as well as the rapid evolution of pathological classification and therapeutic targets,traditional clinical teaching models face challenges such as outdated guideline updates,disjointed translation of scientific research,and limited skill training.This study proposes a dynamic training model integrating“guidelines,clinical practice,and scientific research.”Through stratified case-based teaching(e.g.,FibroScan simulator and metabolic sand table),dynamic guideline analysis(comparing old and new evidence),and the integration of scientific thinking(visualization of CAND1 protein mechanism),a teaching system that integrates theory and practice is constructed.Innovatively developed smart assistant tools(AI decision support system,VR liver biopsy simulator)and a multi-dimensional evaluation system(deviation analysis of diagnosis and treatment pathways,milestone assessment)are used while emphasizing metabolic medicine integration(continuous glucose monitoring and digital therapy)and ethical privacy protection(federated learning framework).This model aims to cultivate students’evidence-based decision-making skills and scientific research transformation thinking through dynamic knowledge base construction and interdisciplinary collaboration,providing sustainable teaching solutions to cope with the rapid iteration of NAFLD diagnosis and treatment.展开更多
The evolving nomenclature from non-alcoholic fatty liver disease(NAFLD)to metabolic dysfunction-associated steatotic liver disease(MASLD)aims to better encompass the metabolic context of the disease.This change has si...The evolving nomenclature from non-alcoholic fatty liver disease(NAFLD)to metabolic dysfunction-associated steatotic liver disease(MASLD)aims to better encompass the metabolic context of the disease.This change has significant implications for patients with type 2 diabetes mellitus(T2DM),given the frequent overlap between these conditions.This minireview explores the rationale behind the change,compares diagnostic criteria,and evaluates the impact of the MASLD framework on disease prevalence,characterization,and outcomes in T2DM patients.The updated MASLD criteria include all individuals with T2DM and hepatic steatosis,emphasizing metabolic dysfunction as the primary driver.In contrast,the NAFLD definition necessitates excluding other chronic liver diseases and verifying the absence of significant alcohol consumption,leading to a narrower diagnostic framework.Both metabolic dysfunction-associated fatty liver disease and MASLD identify a higher prevalence of steatotic liver disease,particularly among T2DM patients,compared to NAFLD.Notably,the MASLD framework introduces metabolic and alcohol-associated liver disease to account for dual etiologies involving alcohol use,which is common in T2DM populations but previously excluded under NAFLD criteria.While the new definitions enhance clinical relevance and inclusivity,they also highlight challenges such as unrecognized medication-induced steatosis and the need for reclassification in ongoing T2DM clinical trials.Emerging evidence supports enhanced screening strategies(e.g.,fibrosis-4)and metabolic-targeted treatments for MASLD in T2DM patients.The successful integration of MASLD into clinical practice will require system-wide reeducation,standardization,and multidisciplinary collaboration to improve outcomes for T2DM patients.展开更多
BACKGROUND Improving our understanding of whether increased dietary intake ofω-3 polyunsaturated fatty acids(PUFAs)is beneficial for increasing skeletal muscle mass in patients with metabolic dysfunction-associated f...BACKGROUND Improving our understanding of whether increased dietary intake ofω-3 polyunsaturated fatty acids(PUFAs)is beneficial for increasing skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease(MAFLD)could provide an important clinical evidence base for the development of relevant nutritional guidelines.AIM To investigate the effect of total dietaryω-3 PUFAs and their subtypes on skeletal muscle mass in MAFLD.METHODS This cross-sectional study involved 2316 participants from four National Health and Nutrition Examination Survey cycles between 2011 and 2018.Dietary intake ofω-3 PUFAs was collected through 24-hour dietary recall interviews.Appendicular skeletal muscle mass index(ASMI)was calculated by dividing ASM in kilograms by height squared.RESULTS The multiple linear regression model showed significant relationships for dietary intake of totalω-3 PUFAs with higher ASMI(β:0.06,95%CI:0.01-0.11)in MAFLD patients.Dietary a-linolenic acid(ALA)(β:0.06,95%CI:0.01-0.12),docosapentaenoic acid(β:1.28,95%CI:0.01-2.54),and docosahexaenoic acid(DHA)(β:0.19,95%CI:0.01-0.37)were significantly associated with higher ASMI,while intake of stearidonic acid and eicosapentaenoic acid did not improve ASMI.In patients with high probability of liver fibrosis,dietary intake of ALA was associated with higher ASMI(β:0.11,95%CI:0.03-0.18).Stratified analysis found that DHA was associated with higher ASMI in patients with obesity and higher metabolic risk.CONCLUSION Increasing dietary intake ofω-3 PUFAs improved skeletal muscle health in patients with MAFLD.Patient with obesity and higher metabolic risk were more likely to benefit from intake of DHA.展开更多
Fatty acids are the main constituents of vegetable oils.To determine the fatty acid compositions of small trade vegetable oils and some less well studied beneficial vegetable oils,and investigate their relationships w...Fatty acids are the main constituents of vegetable oils.To determine the fatty acid compositions of small trade vegetable oils and some less well studied beneficial vegetable oils,and investigate their relationships with antioxidant activity and oxidative stability,gas chromatography-mass spectrometry was performed to characterize the associated fatty acid profiles.The antioxidant activity of vegetable oils,based on their DPPH-scavenging capacity(expressed as IC_(50) values),was used to assess their impact on human health,and their oxidative stability was characterized by performing lipid oxidation analysis to determine the oxidative induction time of fats and oils.In addition,correlation analyses were performed to examine associations between the fatty acid composition of the oils and DPPH-scavenging capacity and oxidative stability.The results revealed that among the assessed oils,coffee seed oil has the highest saturated fatty acid content(355.10 mg/g),whereas Garddenia jaminoides oil has the highest unsaturated fatty acid content(844.84 mg/g).Coffee seed oil was also found have the lowest DPPH IC_(50) value(2.30 mg/mL)and the longest oxidation induction time(17.09 h).Correlation analysis revealed a significant linear relationship(P<0.05)between oxidative stability and unsaturated fatty acid content,with lower contents tending to be associated with better oxidative stability.The findings of this study provide reference data for the screening of functional edible vegetable oils.展开更多
Recently,a single letter change has taken the world by storm.A group of experts have developed a consensus to upgrade the term non-alcoholic fatty liver disease(NAFLD)to metabolic associated fatty liver disease(MAFLD)...Recently,a single letter change has taken the world by storm.A group of experts have developed a consensus to upgrade the term non-alcoholic fatty liver disease(NAFLD)to metabolic associated fatty liver disease(MAFLD),suggesting that MAFLD would more accurately reflect not only the disease pathogenesis but would also help in patient stratification for management with NAFLD.However,the difference of opinion exists,which has made the NAFLD vs MAFLD debate the current talk of the town.This review will focus on the plausibility and implications of redefining NAFLD as MAFLD.展开更多
BACKGROUND Duodenal mucosal ablation(DMA)using irreversible electroporation(IRE)with a glucagon-like peptide-1 receptor agonist has been clinically shown to reduce liver lipid deposition in non-alcoholic fatty liver d...BACKGROUND Duodenal mucosal ablation(DMA)using irreversible electroporation(IRE)with a glucagon-like peptide-1 receptor agonist has been clinically shown to reduce liver lipid deposition in non-alcoholic fatty liver disease(NAFLD).However,the specific metabolic contributions of DMA using IRE in NAFLD remain unclear.AIM To assess the feasibility and effectiveness of DMA using IRE in NAFLD rat models.METHODS Seven-week-old male Sprague-Dawley rats underwent DMA using IRE after 8 weeks on a high-fat diet.Two weeks post-treatment,duodenal and liver tissues and blood samples were collected.We evaluated differences in the duodenal wall structure,liver lipid deposition,enteroendocrine,claudin,and zonula ocludens-1 in the duodenal mucosa.RESULTS DMA using IRE could be safely performed in rats with NAFLD without duodenal bleeding,perforation,or stenosis.The duodenum healed well 2 weeks after DMA and was characterized by slimmer villi,narrower and shallower crypts,and thicker myenterons compared with the sham-control setting.Liver lipid deposition was reduced and serum lipid index parameters were considerably improved in the DMA setting.However,these improvements were independent of food intake and weight loss.In addition,enteroendocrine parameters,such as claudin,and zonula ocludens-1 levels in the duodenal mucosa,differed between the different settings in the DMA group.CONCLUSION By altering enteroendocrine and duodenal permeability,simple DMA using IRE ameliorated liver lipid deposition and improved serum lipid parameters in NAFLD rats.展开更多
Background Caffeic acid(CA)and its derivative,chlorogenic acid(CGA),have shown promise in preventing and alleviating fatty liver disease.CA,compared to CGA,has much lower production costs and higher bioavailability,ma...Background Caffeic acid(CA)and its derivative,chlorogenic acid(CGA),have shown promise in preventing and alleviating fatty liver disease.CA,compared to CGA,has much lower production costs and higher bioavailability,making it a potentially superior feed additive.However,the efficacy,mechanistic differences,and comparative impacts of CA and CGA on fatty liver disease in laying hens remain unclear.This study aimed to evaluate and compare the effects of CA and CGA on production performance,egg quality,and fatty liver disease in laying hens.Results A total of 1,44061-week-old Hyline Brown laying hens were randomly divided into 8 groups and fed diets supplemented with basal diet,25,50,100 and 200 mg/kg of CA,and 100,200 and 400 mg/kg of CGA(CON,CA25,CA50,CA100,CA200,CGA100,CGA200 and CGA400,respectively)for 12 weeks.Both CA and CGA improved production performance and egg quality,while reducing markers of hepatic damage and lipid accumulation.CA and CGA significantly decreased TG,TC,and LDL-C levels and increased T-SOD activity.Transcriptomic and proteomic analyses revealed that CA and CGA reduced hepatic lipid accumulation through downregulation of lipid biosynthesis-related genes(ACLY,ACACA,FASN,and SCD1)and enhanced lipid transport and oxidation genes(FABPs,CD36,CPT1A,ACOX1,and SCP2).Of note,low-dose CA25 exhibited equivalent efficacy to the higher dose CGA100 group in alleviating fatty liver conditions.Mechanistically,CA and CGA alleviated lipid accumulation via activation of the ADPN-AMPK-PPARαsignaling pathway.Conclusions This study demonstrates that dietary CA and CGA effectively improve laying performance,egg quality,and hepatic lipid metabolism in laying hens,with CA potentially being more economical and efficient.Transcriptomic and proteomic evidence highlight shared mechanisms between CA25 and CGA100.These findings provide a foundation for CA and CGA as therapeutic agents for fatty liver disease and related metabolic diseases in hens,and also offer insights into the targeted modification of CGA(including the isomer of CGA)into CA,thereby providing novel strategies for the efficient utilization of CGA.Highlights(1)Dietary CA and CGA improve fatty liver,laying performance and egg quality.(2)Lower dose of CA25 achieves the equivalent improvement as CGA100 or CGA200.(3)CA and CGA mediate the ADPN-AMPK-PPARαpathway to alleviate fatty liver.展开更多
The recent study exploring the bidirectional associations between gallstone disease,non-alcoholic fatty liver disease,and kidney stone disease highlights a critical concern in chronic disease management.Given the risi...The recent study exploring the bidirectional associations between gallstone disease,non-alcoholic fatty liver disease,and kidney stone disease highlights a critical concern in chronic disease management.Given the rising global prevalence of these conditions,understanding their interconnections is essential.The study emphasizes the importance of shared risk factors,such as obesity,type 2 diabetes,dyslipidemia,and oxidative stress,and calls for multidisciplinary screening strategies.This approach would improve patient outcomes and reduce the socio-economic burden.While the study contributes valuable insights from a Chinese population,further research across diverse populations is necessary to validate and extend these findings globally.Ultimately,the research underscores the need for integrated prevention programs to better manage these interconnected diseases and improve health outcomes.展开更多
Flotation is the most common method to recover valuable minerals by selective adsorption of collectors on target mineral surfaces.However,in subsequent hydrometallurgy of mineral flotation concentrates,the adsorbed co...Flotation is the most common method to recover valuable minerals by selective adsorption of collectors on target mineral surfaces.However,in subsequent hydrometallurgy of mineral flotation concentrates,the adsorbed collectors must be desorbed since it can adversely affect the efficiency of metallurgical process and produce wastewater.ZL,as a fatty acid mixture,is a typical industrially used collector for scheelite flotation in China.Sodium oleate(NaOL)has similar fatty acid group as ZL.In this study,the desorption behavior of NaOL/ZL from scheelite surface by a physical method of stirring at a low temperature was investigated.NaOL desorption tests of single mineral showed that a desorption rate of 77.75% for NaOL from scheelite surface into pulp was achieved in a stirring speed of2500 r/min at 5℃in a neutral environment.Under the above desorption condition,in the pulp containing desorbed collector by adding extra 30% normal NaOL dosage,the scheelite recovery reached about 95% in the single mineral flotation test.Desorption and reuse of ZL collector for the flotation of real scheelite ore showed only a 75%normal dosage of ZL could produce a qualified rough concentrate.The atomic force microscope(AFM)tests showed that after desorption treatment of low temperature and strong stirring,the dense strip-like structure of NaOL on the scheelite surface was destroyed to be speck-like.Molecular dynamics simulations(MDS)demonstrated that the adsorption energy between NaOL and scheelite surface was more negative at 25℃(-13.39 kcal/mol)than at 5℃(-11.50 kcal/mol)in a neutral pH,indicating that a low temperature was beneficial for the desorption of collector from mineral surface.Due to its simplicity and economy,the method we proposed of desorption of collector from mineral surface and its reuse for flotation has a great potential for industrial application.展开更多
Background During the transition period,cows are prone to negative energy balance,which can lead to a decline in production performance and health in severe cases.In recent years,it has been discovered that bile acids...Background During the transition period,cows are prone to negative energy balance,which can lead to a decline in production performance and health in severe cases.In recent years,it has been discovered that bile acids(BAs)can act not only as fat emulsifiers but also as signaling molecules to regulate body metabolism.Although BAs have been used to some extent in monogastric and aquatic animals,their role in ruminants,particularly in transition cows,remains unclear.Therefore,this study aimed to determine the effects of BAs on the production performance,milk and plasma fatty acid and BA composition,and fecal microbiota in transition dairy cows.Results Forty-six healthy transition Holstein dairy cows with similar conditions were randomly divided into two groups and supplemented with 0 or 20 g/d of BAs from 21 d before the expected calving to 21 d after calving.The production performance was tracked until 60 d after calving.The results indicated that BA supplementation significantly improved postpartum milk fat content and yields as well as the yields of unsaturated fatty acids,monounsaturated fatty acids,and polyunsaturated fatty acids in milk.There was a significant increase in the concentration of triglyceride and the proportion of C≤16 fatty acids in the plasma of cows supplemented with BAs,while the concentration of β-hydroxybutyrate and the proportion of C>16 fatty acids in the plasma decreased significantly.BA supplementation significantly altered the composition of the fecal bacterial community and increased the relative abundance of bacteria beneficial for BA metabolism and transformation(Romboutsia,Clostridium sensu_stricto_6,and Clostridium sensu_stricto_1).Functional prediction analysis showed that the relative abundance of bile salt hydrolase,7 α-hydroxysteroid dehydrogenase,and BA inducible E as well as the pathways related to BA metabolism also significantly increased in cows supplemented BAs.In addition,BA supplementation significantly altered the composition of plasma and fecal BAs,particularly increasing circulating secondary BA concentration,which might induce the complete oxidation of fatty acids in the liver and further reduce the concentration of β-hydroxybutyrate.Conclusions These findings highlight the potential benefits of BA supplementation in improving milk yields and quality,as well as influencing metabolic pathways in transition dairy cows.Meanwhile,further studies are needed to elucidate the underlying mechanisms and explore the broader implications of these results by using more tissue samples.展开更多
基金supported by the National Key R&D Program of China,No.2021YFC2501200(to PC).
文摘Short-chain fatty acids,metabolites produced by the fermentation of dietary fiber by gut microbiota,have garnered significant attention due to their correlation with neurodegenerative diseases,particularly Parkinson’s disease.In this review,we summarize the changes in short-chain fatty acid levels and the abundance of short-chain fatty acid-producing bacteria in various samples from patients with Parkinson’s disease,highlighting the critical role of gut homeostasis imbalance in the pathogenesis and progression of the disease.Focusing on the nervous system,we discuss the molecular mechanisms by which short-chain fatty acids influence the homeostasis of both the enteric nervous system and the central nervous system.We identify key processes,including the activation of G protein-coupled receptors and the inhibition of histone deacetylases by short-chain fatty acids.Importantly,structural or functional disruptions in the enteric nervous system mediated by these fatty acids may lead to abnormalα-synuclein expression and gastrointestinal dysmotility,which could serve as an initiating event in Parkinson’s disease.Furthermore,we propose that short-chain fatty acids help establish communication between the enteric nervous system and the central nervous system via the vagal nerve,immune circulation,and endocrine signaling.This communication may shed light on their potential role in the transmission ofα-synuclein from the gut to the brain.Finally,we elucidate novel treatment strategies for Parkinson’s disease that target short-chain fatty acids and examine the challenges associated with translating short-chain fatty acid-based therapies into clinical practice.In conclusion,this review emphasizes the pivotal role of short-chain fatty acids in regulating gut-brain axis integrity and their significance in the pathogenesis of Parkinson’s disease from the perspective of the nervous system.Moreover,it highlights the potential value of short-chain fatty acids in early intervention for Parkinson’s disease.Future research into the molecular mechanisms of short-chain fatty acids and their synergistic interactions with other gut metabolites is likely to advance the clinical translation of innovative short-chain fatty acid-based therapies for Parkinson’s disease.
基金supported by the National Natural Science Foundation of China(82574477)the Jiangsu Provincial Traditional Chinese Medicine Science and Technology Development Plan(QN202426)+5 种基金Jiangsu Province“333 High-level Talents Training Project”((2024)3-0189)Youth Talent Support Project of the Jiangsu Association for Science and Technology(TJ-2023-053)Shanxi Provincial Department-Municipal Key Laboratory Cultivation Base for Quality Enhancement and Utilization of Shangdang Chinese Medicinal Materials(KF202401)Fundamental Research Program of Shanxi Province(202403021221211)the research project supported by the Shanxi Scholarship Council of China(No.2023-158)Open Project of Key Laboratory of Tibetan Medicine Basic Research,Ministry of Education.
文摘The global prevalence of metabolic-associated fatty liver disease(MAFLD)is on the rise,seriously threatening human health.Currently,no specific approved drugs are available for its treatment.This paper reviews the pathogenesis of MAFLD,covering aspects like lipid accumulation and insulin resistance,oxidative stress,endoplasmic reticulum stress(ERS),lipotoxicity-induced hepatocyte damage,and fibrosis.It also elaborates on multiple treatment approaches for MAFLD,including metabolic regulation,improvement of the gut-liver axis interaction,modulation of immune and inflammatory pathways,enhancement of the adipose tissue-liver interaction,alleviation of fibrosis,prevention of hepatocyte injury,and traditional Chinese medicine(TCM)external therapies.Additionally,natural product research advancements,individual Chinese medicine components,and mixed herbal formulas for MAFLD treatment is provided.Many natural products and traditional Chinese medicines exhibit favorable effects in regulating lipid metabolism,anti-inflammation,and anti-oxidation,offering new directions and potential drug options for MAFLD treatment.This is expected to provide a reference for future clinical treatment and drug development.
文摘Dysregulated inflammation and multi-organ failure are hallmarks of sepsis,a potentially fatal illness for which there are currently no effective treatments.Fatty acid-binding protein(A-FABP)has been identified in recent research as a crucial mediator of the inflammatory pathways underlying sepsis.In this study,we used a murine model of lipopolysaccharide(LPS)-induced endotoxemia to assess the therapeutic potential of 6H2,a monoclonal antibody that targets A-FABP.In comparison to untreated septic mice,6H2 treatment significantly increased survival rates,decreased histopathological damage in the liver,lungs,kidneys,and heart,and reduced systemic inflammation.According to biochemical analyses,6H2 treatment decreased circulating levels of A-FABP,and this was associated with a reduction in inflammatory markers.These results indicate that A-FABP inhibition is a potentially effective treatment approach for sepsis,with 6H2 demonstrating strong therapeutic efficacy.
基金supported by the Natural Science Foundation of Jiangsu Province,China(BK20241931 and BK 20221371)the National Natural Science Foundation of China(32071943,32372214,and 31901444)the National Key Research and Development Program of China(2022YFD2300304)。
文摘Alternate wetting and drying irrigation(AWD)significantly influences the cooking and eating quality of rice(Oryza sativa L.).However,the mechanisms by which AWD affects rice cooking and eating quality remain unclear.Lipid and free fatty acid contents in grains correlate positively with cooking and eating quality of rice.This study examined Yangdao 6(YD6,a conventional taste indica inbred)and Nanjing 9108(NJ9108,a superior taste japonica inbred)cultivated under conventional irrigation(CI),alternate wetting and moderate drying irrigation(AWMD),and alternate wetting and severe drying irrigation(AWSD)from 10 days after transplanting to maturity.The research investigated the relationship between lipid and free fatty acid biosynthesis in grains and the cooking and eating quality of rice.Compared to CI treatment,AWMD significantly enhanced the contents of lipid,total free fatty acids(TFFAs),free unsaturated fatty acids(FUFAs),linoleic acid,and oleic acid in milled rice by increasing activities of enzymes associated with lipid synthesis,while AWSD produced opposite effects.Correlation analysis revealed that elevated levels of lipid,TFFAs,FUFAs,linoleic acid,and oleic acid contribute to improved rice cooking and eating quality.The findings demonstrate that AWMD enhances cooking and eating quality of milled rice through optimization of lipid and fatty acid synthesis in rice grains.
文摘Epidemiological evidence suggests that there is a direct relationship between the degree of obesity and acute pancreatitis severity.Intake of different fatty acids leads to different types of hyperlipidemias.Adipose degradation by pancreatic lipase generates different free fatty acids,which can exacerbate pancreatitis.Saturated fatty acids(SFAs)play an inflammatory role in human metabolic syndrome and obesity,whereas unsaturated fatty acids(UFAs)are“good fats”that are thought to enhance overall health status.However,it appears that serum UFAs correlate with severe acute pancreatitis.Additionally,the“obesity paradox”suggests that UFAs potentially minimize direct harm to the organ.This review provides an in-depth overview of the role of SFAs and UFAs in acute pancreatitis of hyperlipidemia and discusses potential prevention targets for severe acute pancreatitis.
文摘Non-alcoholic fatty liver disease(NAFLD),also referred to as metabolic-associated fatty liver disease,is among the most prevalent chronic liver conditions.In some cases,NAFLD may lead to liver inflammation and non-alcoholic steatohepatitis,which can eventually progress to liver cirrhosis and hepatocellular carcinoma.The pathophysiology of NAFLD is complex,involving both genetic and environmental factors.NAFLD is a multisystem disease linked to a higher likelihood of developing metabolic disorders such as type 2 diabetes,obesity,and cardiovascular and chronic kidney diseases.The gut-liver axis represents a key connection between the gut microbiota and the liver,and its disruption has been linked to NAFLD.Growing evidence underscores the significant role of gut microbiota in the onset and progression of NAFLD,with alterations in the gut microbiome and impaired gut barrier function.Studies have identified key microbiota signatures and metabolites linked to NAFLD,implicating oxidative stress,endotoxemia,and inflammatory pathways that further strengthen the connection between gut microbiota and NAFLD.Modulation of gut microbiota through diet and microbiota-centered therapies,such as next-generation probiotics and fecal microbiota transplantation,holds promise for treating NAFLD.In this review,we explore the key link between gut microbiota and the development and progression of NAFLD,as well as its potential applications in the diagnosis and treatment of the disease.
文摘Metabolic-associated fatty liver disease(MAFLD),formerly known as nonalcoho-lic fatty liver disease,is an increasing global health challenge with substantial implications for metabolic and cardiovascular health(CVH).A recent study by Fu et al investigated the relationship between CVH metrics,specifically Life’s Simple 7 and Life’s Essential 8,and the prevalence of MAFLD.While this study offered important insights into the relationship between CVH and MAFLD,several me-thodological limitations,unaddressed confounding factors,and potential biases that could impact the interpretation of their findings should be considered.The study’s cross-sectional nature restricted the ability to draw causal conclusions,and it did not fully account for potential confounding factors such as dietary habits,genetic predispositions,and medication use.Furthermore,relying on tran-sient elastography to diagnose MAFLD introduces certain diagnostic limitations.Longitudinal study designs,advanced statistical modeling techniques,and diverse population groups should be utilized to strengthen future research.Exploring the mechanistic pathways that link CVH metrics to MAFLD through multi-omics approaches and interventional studies will be essential in formulating targeted prevention and treatment strategies.Structural equation modeling and machine learning techniques could provide a more refined analysis of these interrelated factors.Additionally,future research should employ longitudinal study designs and explore genetic and epigenetic influences to enhance our un-derstanding of CVH and MAFLD interactions.
基金Supported by DHR Women Scientist Fellowship,No.12013/53/2024.
文摘Non-alcoholic fatty liver disease(NAFLD)is the fastest-growing global contributor to the disease burden associated with the consequences of chronic liver disease,including cirrhosis and liver cancer.It is projected that more than fifty percent of the adult population,including women,smokers,and individuals without metabolic syndrome,will have NAFLD by 2040.Various mechanisms linking the gut microbiome to NAFLD and the consequent fibrosis have been discerned,which suggest the dysbiosis-induced impairment of gut endothelial barrier function,leading to hepatic inflammation through the translocation of bacterial components.NAFLD is progressively associated with environmental variables,especially exposure to heavy metals that impair liver metabolism,produce oxidative stress,and exacerbate inflammation,hence accelerating its progression.These toxicants also modify the composition of gut microbiota,hence intensifying liver damage.Comprehending the processes by which heavy metals contribute to NAFLD is essential for formulating tailored therapies.This review examines strategies to alleviate liver toxicity caused by heavy metals,including chelation therapy,dietary modifications(antioxidants and hepatoprotective nutrients),gut microbiome modulation via probiotics and postbiotics like short-chain fatty acids to restore intestinal barrier function and use of essential minerals like selenium,with potent antioxidant characteristics.Employing these measures may offer an integrated approach for addressing NAFLD in individuals subjected to heavy metal poisoning.
基金Science Research Project of Hebei Education Department(Project No.:QN2022013)。
文摘Non-alcoholic fatty liver disease(NAFLD)has become the most prevalent chronic liver disease globally,with its incidence rising annually.It can progress to cirrhosis and even hepatocellular carcinoma,posing a serious threat to human health.Stress can participate in the pathological process of NAFLD by activating inflammatory responses and regulating levels of inflammatory mediators,with hepatocyte injury being a core component of NAFLD progression.This paper focuses on three key stress-related inflammatory mediators:tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),and C-reactive protein(CRP),elucidating their core mechanisms in the pathway related to stress signal,followed by inflammatory activation and hepatocyte injury respectively,and reviewing current research.Research indicates that certain inflammatory mediators can damage hepatocytes by directly inducing apoptosis or indirectly regulating metabolic disorders and fibrosis progression.However,questions regarding causal relationships,target specificity for intervention,and quantification of psychological stress remain unresolved.This paper aims to provide theoretical support for NAFLD intervention strategies targeting inflammatory mediators,clarifying future research directions to advance clinical translation.
基金American Heart Association Award,No.24IVPHA1288417and FCT Fellowships,No.2022.13253.BDANA.
文摘The potential of induced pluripotent stem cells(iPSCs)for modeling and treating metabolic associated fatty liver disease(MAFLD)and metabolic associated steatohepatitis(MASH)is emerging.MAFLD is a growing global health concern,currently with limited treatment options.While primary mesenchymal stem cells hold promise,iPSCs offer a versatile alternative due to their ability to differentiate into various cell types,including iPSC-derived mesenchymal stem cells.However,challenges remain,including optimizing differentiation protocols,ensuring cell safety,and addressing potential tumorigenicity risks.In addition,iPSCs offer the possibility to generate complex cellular models,including three-dimensional organoid models,which are closer representations of the human disease than animal models.Those models would also be valuable for drug discovery and personalized medicine approaches.Overall,iPSCs and their derivatives offer new perspectives for advancing MAFLD/MASH research and developing novel therapeutic strategies.Further research is needed to overcome current limitations and translate this potential into effective clinical applications.
文摘With the shift in the definition of disease from non-alcoholic fatty liver disease(NAFLD)to metabolism-associated fatty liver disease(MAFLD),as well as the rapid evolution of pathological classification and therapeutic targets,traditional clinical teaching models face challenges such as outdated guideline updates,disjointed translation of scientific research,and limited skill training.This study proposes a dynamic training model integrating“guidelines,clinical practice,and scientific research.”Through stratified case-based teaching(e.g.,FibroScan simulator and metabolic sand table),dynamic guideline analysis(comparing old and new evidence),and the integration of scientific thinking(visualization of CAND1 protein mechanism),a teaching system that integrates theory and practice is constructed.Innovatively developed smart assistant tools(AI decision support system,VR liver biopsy simulator)and a multi-dimensional evaluation system(deviation analysis of diagnosis and treatment pathways,milestone assessment)are used while emphasizing metabolic medicine integration(continuous glucose monitoring and digital therapy)and ethical privacy protection(federated learning framework).This model aims to cultivate students’evidence-based decision-making skills and scientific research transformation thinking through dynamic knowledge base construction and interdisciplinary collaboration,providing sustainable teaching solutions to cope with the rapid iteration of NAFLD diagnosis and treatment.
文摘The evolving nomenclature from non-alcoholic fatty liver disease(NAFLD)to metabolic dysfunction-associated steatotic liver disease(MASLD)aims to better encompass the metabolic context of the disease.This change has significant implications for patients with type 2 diabetes mellitus(T2DM),given the frequent overlap between these conditions.This minireview explores the rationale behind the change,compares diagnostic criteria,and evaluates the impact of the MASLD framework on disease prevalence,characterization,and outcomes in T2DM patients.The updated MASLD criteria include all individuals with T2DM and hepatic steatosis,emphasizing metabolic dysfunction as the primary driver.In contrast,the NAFLD definition necessitates excluding other chronic liver diseases and verifying the absence of significant alcohol consumption,leading to a narrower diagnostic framework.Both metabolic dysfunction-associated fatty liver disease and MASLD identify a higher prevalence of steatotic liver disease,particularly among T2DM patients,compared to NAFLD.Notably,the MASLD framework introduces metabolic and alcohol-associated liver disease to account for dual etiologies involving alcohol use,which is common in T2DM populations but previously excluded under NAFLD criteria.While the new definitions enhance clinical relevance and inclusivity,they also highlight challenges such as unrecognized medication-induced steatosis and the need for reclassification in ongoing T2DM clinical trials.Emerging evidence supports enhanced screening strategies(e.g.,fibrosis-4)and metabolic-targeted treatments for MASLD in T2DM patients.The successful integration of MASLD into clinical practice will require system-wide reeducation,standardization,and multidisciplinary collaboration to improve outcomes for T2DM patients.
基金Supported by The National Natural Science Foundation of China,No.82103356.
文摘BACKGROUND Improving our understanding of whether increased dietary intake ofω-3 polyunsaturated fatty acids(PUFAs)is beneficial for increasing skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease(MAFLD)could provide an important clinical evidence base for the development of relevant nutritional guidelines.AIM To investigate the effect of total dietaryω-3 PUFAs and their subtypes on skeletal muscle mass in MAFLD.METHODS This cross-sectional study involved 2316 participants from four National Health and Nutrition Examination Survey cycles between 2011 and 2018.Dietary intake ofω-3 PUFAs was collected through 24-hour dietary recall interviews.Appendicular skeletal muscle mass index(ASMI)was calculated by dividing ASM in kilograms by height squared.RESULTS The multiple linear regression model showed significant relationships for dietary intake of totalω-3 PUFAs with higher ASMI(β:0.06,95%CI:0.01-0.11)in MAFLD patients.Dietary a-linolenic acid(ALA)(β:0.06,95%CI:0.01-0.12),docosapentaenoic acid(β:1.28,95%CI:0.01-2.54),and docosahexaenoic acid(DHA)(β:0.19,95%CI:0.01-0.37)were significantly associated with higher ASMI,while intake of stearidonic acid and eicosapentaenoic acid did not improve ASMI.In patients with high probability of liver fibrosis,dietary intake of ALA was associated with higher ASMI(β:0.11,95%CI:0.03-0.18).Stratified analysis found that DHA was associated with higher ASMI in patients with obesity and higher metabolic risk.CONCLUSION Increasing dietary intake ofω-3 PUFAs improved skeletal muscle health in patients with MAFLD.Patient with obesity and higher metabolic risk were more likely to benefit from intake of DHA.
文摘Fatty acids are the main constituents of vegetable oils.To determine the fatty acid compositions of small trade vegetable oils and some less well studied beneficial vegetable oils,and investigate their relationships with antioxidant activity and oxidative stability,gas chromatography-mass spectrometry was performed to characterize the associated fatty acid profiles.The antioxidant activity of vegetable oils,based on their DPPH-scavenging capacity(expressed as IC_(50) values),was used to assess their impact on human health,and their oxidative stability was characterized by performing lipid oxidation analysis to determine the oxidative induction time of fats and oils.In addition,correlation analyses were performed to examine associations between the fatty acid composition of the oils and DPPH-scavenging capacity and oxidative stability.The results revealed that among the assessed oils,coffee seed oil has the highest saturated fatty acid content(355.10 mg/g),whereas Garddenia jaminoides oil has the highest unsaturated fatty acid content(844.84 mg/g).Coffee seed oil was also found have the lowest DPPH IC_(50) value(2.30 mg/mL)and the longest oxidation induction time(17.09 h).Correlation analysis revealed a significant linear relationship(P<0.05)between oxidative stability and unsaturated fatty acid content,with lower contents tending to be associated with better oxidative stability.The findings of this study provide reference data for the screening of functional edible vegetable oils.
文摘Recently,a single letter change has taken the world by storm.A group of experts have developed a consensus to upgrade the term non-alcoholic fatty liver disease(NAFLD)to metabolic associated fatty liver disease(MAFLD),suggesting that MAFLD would more accurately reflect not only the disease pathogenesis but would also help in patient stratification for management with NAFLD.However,the difference of opinion exists,which has made the NAFLD vs MAFLD debate the current talk of the town.This review will focus on the plausibility and implications of redefining NAFLD as MAFLD.
基金Supported by the National Key Research and Development Program,No.2023YFF0713700 and No.2023YFF0713705Common Technology R&D Platform of Shaanxi Province,No.2023GXJS-01-1-2the Cyrus Tang Foundation Chung Ying Young Scholars Program.
文摘BACKGROUND Duodenal mucosal ablation(DMA)using irreversible electroporation(IRE)with a glucagon-like peptide-1 receptor agonist has been clinically shown to reduce liver lipid deposition in non-alcoholic fatty liver disease(NAFLD).However,the specific metabolic contributions of DMA using IRE in NAFLD remain unclear.AIM To assess the feasibility and effectiveness of DMA using IRE in NAFLD rat models.METHODS Seven-week-old male Sprague-Dawley rats underwent DMA using IRE after 8 weeks on a high-fat diet.Two weeks post-treatment,duodenal and liver tissues and blood samples were collected.We evaluated differences in the duodenal wall structure,liver lipid deposition,enteroendocrine,claudin,and zonula ocludens-1 in the duodenal mucosa.RESULTS DMA using IRE could be safely performed in rats with NAFLD without duodenal bleeding,perforation,or stenosis.The duodenum healed well 2 weeks after DMA and was characterized by slimmer villi,narrower and shallower crypts,and thicker myenterons compared with the sham-control setting.Liver lipid deposition was reduced and serum lipid index parameters were considerably improved in the DMA setting.However,these improvements were independent of food intake and weight loss.In addition,enteroendocrine parameters,such as claudin,and zonula ocludens-1 levels in the duodenal mucosa,differed between the different settings in the DMA group.CONCLUSION By altering enteroendocrine and duodenal permeability,simple DMA using IRE ameliorated liver lipid deposition and improved serum lipid parameters in NAFLD rats.
基金supported by National Key R&D Program of China(2023YFD1301200)China Agriculture Research Systems(CARS-40-K11)+2 种基金Beijing Agriculture Innovation Consortium(BAIC06-2024-G05)Strategic Priority Research Program of the National Center of Technology Innovation for Pigs(NCTIP-XD/C08)The Chinese Academy of Agricultural Science and Technology Innovation Project(ASTIP-IAS-12)。
文摘Background Caffeic acid(CA)and its derivative,chlorogenic acid(CGA),have shown promise in preventing and alleviating fatty liver disease.CA,compared to CGA,has much lower production costs and higher bioavailability,making it a potentially superior feed additive.However,the efficacy,mechanistic differences,and comparative impacts of CA and CGA on fatty liver disease in laying hens remain unclear.This study aimed to evaluate and compare the effects of CA and CGA on production performance,egg quality,and fatty liver disease in laying hens.Results A total of 1,44061-week-old Hyline Brown laying hens were randomly divided into 8 groups and fed diets supplemented with basal diet,25,50,100 and 200 mg/kg of CA,and 100,200 and 400 mg/kg of CGA(CON,CA25,CA50,CA100,CA200,CGA100,CGA200 and CGA400,respectively)for 12 weeks.Both CA and CGA improved production performance and egg quality,while reducing markers of hepatic damage and lipid accumulation.CA and CGA significantly decreased TG,TC,and LDL-C levels and increased T-SOD activity.Transcriptomic and proteomic analyses revealed that CA and CGA reduced hepatic lipid accumulation through downregulation of lipid biosynthesis-related genes(ACLY,ACACA,FASN,and SCD1)and enhanced lipid transport and oxidation genes(FABPs,CD36,CPT1A,ACOX1,and SCP2).Of note,low-dose CA25 exhibited equivalent efficacy to the higher dose CGA100 group in alleviating fatty liver conditions.Mechanistically,CA and CGA alleviated lipid accumulation via activation of the ADPN-AMPK-PPARαsignaling pathway.Conclusions This study demonstrates that dietary CA and CGA effectively improve laying performance,egg quality,and hepatic lipid metabolism in laying hens,with CA potentially being more economical and efficient.Transcriptomic and proteomic evidence highlight shared mechanisms between CA25 and CGA100.These findings provide a foundation for CA and CGA as therapeutic agents for fatty liver disease and related metabolic diseases in hens,and also offer insights into the targeted modification of CGA(including the isomer of CGA)into CA,thereby providing novel strategies for the efficient utilization of CGA.Highlights(1)Dietary CA and CGA improve fatty liver,laying performance and egg quality.(2)Lower dose of CA25 achieves the equivalent improvement as CGA100 or CGA200.(3)CA and CGA mediate the ADPN-AMPK-PPARαpathway to alleviate fatty liver.
文摘The recent study exploring the bidirectional associations between gallstone disease,non-alcoholic fatty liver disease,and kidney stone disease highlights a critical concern in chronic disease management.Given the rising global prevalence of these conditions,understanding their interconnections is essential.The study emphasizes the importance of shared risk factors,such as obesity,type 2 diabetes,dyslipidemia,and oxidative stress,and calls for multidisciplinary screening strategies.This approach would improve patient outcomes and reduce the socio-economic burden.While the study contributes valuable insights from a Chinese population,further research across diverse populations is necessary to validate and extend these findings globally.Ultimately,the research underscores the need for integrated prevention programs to better manage these interconnected diseases and improve health outcomes.
基金financially supported by the National Natural Science Foundation of China(Nos.52304314 and U23A20602)the Open Fund of the Key Laboratory of Mineral Metallurgical Resources Utilization and Pollution Control,Ministry of Ecology and Environment+3 种基金China(No.HB202406)the Fundamental Research Funds for the Central Universities of Central South University,China(Nos.CX20240021 and 2024ZZTS0008)the Innovation and Entrepreneurship Funding Project for College Students of Central South UniversityChina(No.S202410533166)。
文摘Flotation is the most common method to recover valuable minerals by selective adsorption of collectors on target mineral surfaces.However,in subsequent hydrometallurgy of mineral flotation concentrates,the adsorbed collectors must be desorbed since it can adversely affect the efficiency of metallurgical process and produce wastewater.ZL,as a fatty acid mixture,is a typical industrially used collector for scheelite flotation in China.Sodium oleate(NaOL)has similar fatty acid group as ZL.In this study,the desorption behavior of NaOL/ZL from scheelite surface by a physical method of stirring at a low temperature was investigated.NaOL desorption tests of single mineral showed that a desorption rate of 77.75% for NaOL from scheelite surface into pulp was achieved in a stirring speed of2500 r/min at 5℃in a neutral environment.Under the above desorption condition,in the pulp containing desorbed collector by adding extra 30% normal NaOL dosage,the scheelite recovery reached about 95% in the single mineral flotation test.Desorption and reuse of ZL collector for the flotation of real scheelite ore showed only a 75%normal dosage of ZL could produce a qualified rough concentrate.The atomic force microscope(AFM)tests showed that after desorption treatment of low temperature and strong stirring,the dense strip-like structure of NaOL on the scheelite surface was destroyed to be speck-like.Molecular dynamics simulations(MDS)demonstrated that the adsorption energy between NaOL and scheelite surface was more negative at 25℃(-13.39 kcal/mol)than at 5℃(-11.50 kcal/mol)in a neutral pH,indicating that a low temperature was beneficial for the desorption of collector from mineral surface.Due to its simplicity and economy,the method we proposed of desorption of collector from mineral surface and its reuse for flotation has a great potential for industrial application.
基金supported by the National Center of Technology Innovation for Dairy(No.2024-JSGG-021)the National Natural Science Foundation of China(No.32102570)the Key Research and Development Project of Ningxia(No.2024BBF01006).
文摘Background During the transition period,cows are prone to negative energy balance,which can lead to a decline in production performance and health in severe cases.In recent years,it has been discovered that bile acids(BAs)can act not only as fat emulsifiers but also as signaling molecules to regulate body metabolism.Although BAs have been used to some extent in monogastric and aquatic animals,their role in ruminants,particularly in transition cows,remains unclear.Therefore,this study aimed to determine the effects of BAs on the production performance,milk and plasma fatty acid and BA composition,and fecal microbiota in transition dairy cows.Results Forty-six healthy transition Holstein dairy cows with similar conditions were randomly divided into two groups and supplemented with 0 or 20 g/d of BAs from 21 d before the expected calving to 21 d after calving.The production performance was tracked until 60 d after calving.The results indicated that BA supplementation significantly improved postpartum milk fat content and yields as well as the yields of unsaturated fatty acids,monounsaturated fatty acids,and polyunsaturated fatty acids in milk.There was a significant increase in the concentration of triglyceride and the proportion of C≤16 fatty acids in the plasma of cows supplemented with BAs,while the concentration of β-hydroxybutyrate and the proportion of C>16 fatty acids in the plasma decreased significantly.BA supplementation significantly altered the composition of the fecal bacterial community and increased the relative abundance of bacteria beneficial for BA metabolism and transformation(Romboutsia,Clostridium sensu_stricto_6,and Clostridium sensu_stricto_1).Functional prediction analysis showed that the relative abundance of bile salt hydrolase,7 α-hydroxysteroid dehydrogenase,and BA inducible E as well as the pathways related to BA metabolism also significantly increased in cows supplemented BAs.In addition,BA supplementation significantly altered the composition of plasma and fecal BAs,particularly increasing circulating secondary BA concentration,which might induce the complete oxidation of fatty acids in the liver and further reduce the concentration of β-hydroxybutyrate.Conclusions These findings highlight the potential benefits of BA supplementation in improving milk yields and quality,as well as influencing metabolic pathways in transition dairy cows.Meanwhile,further studies are needed to elucidate the underlying mechanisms and explore the broader implications of these results by using more tissue samples.
